$FCNCA

Alemany Ellen R sold $5.2M of FCNCA (indirect holdings)

Alemany Ellen R sold 2,520 indirectly-held shares of FIRST CITIZENS BANCSHARES INC /DE/ (FCNCA) at an average of $2047.12 ($2033.33–$2052.43, $5.16M total) across 8 trades on 2026-06-04.

Original reporting
SEC EDGAR · Alemany Ellen R
Published Jun 8, 2026, 7:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FCNCA
Neutral
medium confidence
Mentioned
$FCNCA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FCNCANeutralLow
01

Why it matters

The newest fact is the director’s open-market sale totaling about $5.16M at ~$2,033–$2,052 per share; this may slightly pressure sentiment but does not, by itself, change fundamentals.

02

Market read

Traders may monitor FCNCA for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without additional company news.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says 'No'), but it also provides no context on taxes, diversification, or prior planned sales.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-08; sale executed 2026-06-04.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for First Citizens BancShares, Inc. (FCNCA).

Company-level read

Ticker impact

$FCNCANeutralMedium confidence
Context

SEC Form 4 shows director Alemany Ellen R sold $5.16M of FCNCA shares via open-market transactions on 2026-06-04.

Expected impact

Likely limited near-term impact; any effect should be small unless accompanied by broader company-specific news.

Evidence & confidence

The filing is a routine insider-sale disclosure (no 10b5-1 plan stated) with no accompanying operational/regulatory/earnings catalyst in the article.

Market effects

No sector-level read-through; this is a single-company insider transaction.

None indicated beyond company-specific sentiment.

None indicated.

Counterpoint

Director sales can be driven by diversification or personal liquidity needs rather than bearish expectations, especially when executed across multiple small trades.

Key entities

  • FIRST CITIZENS BANCSHARES INC /DE/

    Subject of the SEC Form 4 insider transaction disclosure.

  • Alemany Ellen R

    Director who sold FCNCA shares via open-market sale.

Related articles

$FCNCAMed

First Citizens says it's repaid $8.5B tied to SVB acquisition

First Citizens BancShares said it repaid $8.5 billion to the FDIC to reduce debt tied to its Silicon Valley Bank acquisition. It paid $2.5 billion on an FDIC purchase money note in Q2 and another $1 billion in July, with planned monthly payments of $500 million to $1 billion. The bank reported Q2 net interest income of $1.66 billion and net income of $672 million.

$FCNCAMedAI 8/10

First Citizens BancShares Reports Second Quarter 2026 Earnings

First Citizens BancShares (Nasdaq: FCNCA) reported Q2 2026 net income of $672 million, up from $534 million in Q1 2026. Adjusted net income rose to $691 million. Net interest income increased to $1.66 billion and NIM was 3.10%. The bank also agreed to acquire 138 BMO branches, expecting $5.3B deposits and $700M loans by Q3 2026.

$FCNCAMed

FIRST CITIZENS BANCSHARES INC /DE/ (FCNCA): Results of Operations and Financial Condition

FIRST CITIZENS BANCSHARES INC /DE/ (FCNCA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 ex_993financialsupplement-.htm EX-99.3 Document Financial Supplement First Citizens BancShares, Inc. June 30, 2026 Summary Financial Data and Metrics Three Months Ended Increase (Decrease) From LQ (4) Six Months Ended Increase (Decrease) From PYTD dollars in millions, e

$AMCRLowAI 8/10

New Jersey Rep. Tom Kean Jr. ditched Congress for 75 days citing illness. Someone went digging and found out exactly what he's been up to.

New Jersey Rep. Tom Kean Jr. has been absent from Congress for 75 days, citing illness, but records cited by The New Republic and NOTUS say he traveled and traded stocks during the period. He skipped 88 House votes since March 5. NOTUS reports trades in Amcor, Chubb, First Citizens BancShares, Johnson & Johnson, and PepsiCo totaling $50,008–$190,000.